公開日期 | 標題 | 作者 | 來源出版物 | WOS | 全文 |
1995 | SIGNALING THROUGH CD19 ACTIVATES AP1 TRANSCRIPTION FACTORS IN HUMAN B-LINEAGE CELLS | Wen-Kai Weng ; Obrien, D.; Vanness, B.; Lebien, T. W. | Faseb Journal | | |
2016 | A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT) | Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A. | Blood | | |
2001 | Studies on modifications of ITO surfaces in OLED devices by Taguchi methods | Liu, J. M.; Lu, P. Y.; Wen-Kai Weng | Materials Science and Engineering B-Solid State Materials for Advanced Technology | | |
2020 | Study of a deep draft vessel to enhance onsite installation capability of a jack up type unit operating in the wind farm zone offshore of the Taichung Harbor Taiwan | Y.Z. Kehr; G.A. Chang; G.J. Huang; Wen-Kai Weng | OCEAN ENG | 1 | |
2016 | A Study of Long Wave Attenuation over Composite Undulating Breakwaters | Shih, Ruey-Syan ; Weng, Wen-Kai | J COASTAL RES | 5 | |
2016 | Study on the Energy Conversion Efficiency Enhancement of a Fixed Point Absorption Wave Converter | Chi-Yu Li ; Fong-Lin Chen; Wen-Kai Weng | | | |
2012 | Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma | Chen, A. I.; Negrin, R. S.; McMillan, A.; Shizuru, J. A.; Johnston, L. J.; Lowsky, R.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Laport, G. G.; Stockerl-Goldstein, K. | Bone Marrow Transplantation | | |
2013 | Targeting CD137 to enhance the antitumor efficacy of cetuximab by stimulation of innate and adaptive immunity | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Lira, R. R.; Troutner, E.; Richards, L.; Rajapaksa, A.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Colevas, C. A. D.; Sunwoo, J.; Levy, R. | Journal of Clinical Oncology | | |
2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |
2013 | TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN | Benjamin, J.; Chhabra, S.; Kohrt, H.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | |
2014 | Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms | Benjamin, J.; Chhabra, S.; Kohrt, H. E.; Lavori, P.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | |
2012 | Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts | Lee, C. S.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D. E.; Armstrong, R.; Wen-Kai Weng ; Aros, C. J.; Mah, A.; Chen, R. O.; Lin, M. H.; Sundram, U.; Chang, H. Y.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Blood | | |
2019 | Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients | Meyer, E. H.; Laport, G.; Xie, B. J.; MacDonald, K.; Heydari, K.; Sahaf, B.; Tang, S. W.; Baker, J.; Armstrong, R.; Tate, K.; Tadisco, C.; Arai, S.; Johnston, L.; Lowsky, R.; Muffly, L.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Sheehan, K.; Miklos, D.; Negrin, R. S. | Jci Insight | | |
2009 | Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma | Timmerman, J. M.; Vose, J. M.; Czerwinski, D. K.; Wen-Kai Weng ; Ingolia, D.; Mayo, M.; Denney, D. W.; Levy, R. | Leukemia & Lymphoma | | |
2003 | Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma | Wen-Kai Weng ; Levy, R. | Journal of Clinical Oncology | | |
2005 | Use of dendritic cells and GM-CSF adjuvant are associated with anti-idiotype cellular immune response following idiotype vaccination in follicular lymphoma patients | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | | |
2014 | Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Hoppe, R. T.; Meyer, E. H.; Kim, Y. H. | Blood | | |
2014 | The utility of HTS TCR analyses in the management of patients with T-cell malignancies | Kirsch, I. L.; Sherwood, A.; Williamson, D.; Wen-Kai Weng ; Clark, R.; Kupper, T. S.; Wu, D.; Robins, H. | Journal of Clinical Oncology | | |
2016 | Validation of the hematopoietic cell transplantation-specific comorbidity index in non-myeloablative allogeneic stem cell transplantation | Veeraputhiran, M.; Arai, S.; Lowsky, R.; Miklos, D. B.; Meyer, E.; Muffly, L. S.; Negrin, R.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. J. | Journal of Clinical Oncology | | |
2017 | Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation | Veeraputhiran, M.; Yang, L. Y.; Sundaram, V.; Arai, S.; Lowsky, R.; Miklos, D.; Meyer, E.; Muffly, L.; Negrin, R.; Rezvani, A.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. | Biology of Blood and Marrow Transplantation | | |